Abstract

PT30 Will Health Technology Assessment (HTA) Bodies in Europe Accept Evidence from an External Control Arm to Supplement Evidence from Clinical Trials for Chronic Diseases?

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
VP216 Health Technology Assessment's Balance Between Additional Data, Adoption, And Patient Access
Parashar Patel ... Michael Cangelosi
International Journal of Technology Assessment in Health Care | VOL. 33
Parashar Patel, et. al.Parashar Patel ... Michael Cangelosi
01 Jan 2017
OP137 A Qualitative Exploration Of The National Institute For Health And Care Excellence’s Impact On International Health Technology Assessment
Nadine Henderson ... Martina Garau
International Journal of Technology Assessment in Health Care | VOL. 39
Nadine Henderson, et. al.Nadine Henderson ... Martina Garau
01 Dec 2023
PHP276 - Understanding Health Technology Assessment (HTA) Bodies in Major European Markets: Systematic Evaluation in 10 EU Countries
M Nanavaty ... M Mwamburi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 19
M Nanavaty, et. al.M Nanavaty ... M Mwamburi
31 Oct 2016
PHP293 - Understanding Health Technology Assessment (HTA) Bodies in Major Latin-American (LATAM) Markets: Systematic Evaluation in 5 Latam Countries
M Nanavaty ... M Mwamburi
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 19
M Nanavaty, et. al.M Nanavaty ... M Mwamburi
31 Oct 2016
View more papers

More From: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Paper Title
Journal
Date
Author
The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set
-
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
--
21 Jun 2024
Market entry agreements for innovative pharmaceuticals subject to indication broadening: a case study for pembrolizumab in the Netherlands.
Renaud J S D Heine ... Carin A Uyl-De Groot
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. -
Renaud J S D Heine, et. al.Renaud J S D Heine ... Carin A Uyl-De Groot
21 Jun 2024
MSR99 A Stacked Ensemble Approach for Building Composite Measure Models in Healthcare
P Shi ... S Zhang
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
P Shi, et. al.P Shi ... S Zhang
15 Jun 2024
EE98 A Theory-Based Framework to Incorporate Health Equity in Economic Assessments
S Subramanian ... S Hoover
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research | VOL. 27
S Subramanian, et. al.S Subramanian ... S Hoover
15 Jun 2024
View more papers